Prospective cohort study of vitamin D deficiency in pregnancy: Prevalence and limited effectiveness of 1000 IU vitamin D supplementation
Date
2024-01-28Author
Abdelmageed, Rasha MohammedHussein, Suha Majeed Mohammed
Anamangadan, Shamil Mohamed
Abdullah, Rola Walid Mahmoud
Rauf, Lubna
AlFehaidi, Al Anoud Saleh
Hamed, Ehab
...show more authors ...show less authors
Metadata
Show full item recordAbstract
Background: Vitamin D deficiency is highly prevalent worldwide among pregnant women. Although vitamin D supplementation is effective in improving vitamin D status, the safety and optimal dosing of vitamin D supplementation during pregnancy remain less well understood. Objective: This study aimed to investigate the prevalence of vitamin D deficiency among pregnant women and evaluate the effectiveness of vitamin D supplementation in improving vitamin D status during pregnancy. Design: This prospective cohort study assessed the impact of a 16-week daily vitamin D supplementation 1000 IU regimen on vitamin D status among pregnant women. Methods: A total of 365 pregnant women were recruited, and their baseline total circulating 25-hydroxy vitamin D concentrations were measured. Of these, 249 participants completed the study, which involved oral daily supplementation with 1000 IU of vitamin D and a repeat of total circulating 25-hydroxy vitamin D concentrations after 16 weeks. Results: The study found that 57.7% of the participants had vitamin D deficiency, consistent with the rates reported in other studies. However, vitamin D supplementation at a dose of 1000 IU had a small effect size and was not clinically significant. However, 67% of participants with vitamin D deficiency remained deficient; among participants initially with vitamin D insufficiency, 30% became deficient. Moreover, 26.5% of individuals with sufficient vitamin D status at 12 weeks showed insufficient levels by 28 weeks. Conclusion: Vitamin D deficiency is widespread among pregnant women, and vitamin D supplementation at a daily dose of 1000 IU may not adequately address this problem. Although the study has limitations, its results align with previous research and may apply to other populations with a high prevalence of vitamin D deficiency during pregnancy. Further research is necessary to determine the most effective approach for addressing prenatal vitamin D deficiency.
Collections
- QU Health Research [77 items ]
Related items
Showing items related by title, author, creator and subject.
-
25-Hydroxyvitamin D Concentrations and Clostridium difficile Infection: A Meta-Analysis
Furuya-Kanamori, L.; Wangdi, K.; Yakob, L.; McKenzie, S.J.; Doi, S.A.R.; Clark, J.; Paterson, D.L.; Riley, T.V.; Clements, A.C.A.... more authors ... less authors ( SAGE Publications Inc. , 2017 , Article)Background: Well-known risk factors for Clostridium difficile infection (CDI) are exposure to antibiotics and gastric acid suppressants. Recent studies have provided some evidence of an association between hypovitaminosis ... -
Reply to "Double-counting of effect sizes and inappropriate exclusion of studies in "The influence of vitamin D supplementation on IGF-1 levels in humans: A systematic review and meta_analysis"
Kord-Varkaneh, Hamed; Rinaldi, Giulia; Hekmatdoost, Azita; Fatahi, Somaye; Tan, Shing Cheng; Shadnoush, Mahdi; Khni, Vahid; Mousavi, Seyed Mohammad; Zarezadeh, Meysam; Salamat, Shekoufeh; Bawadi, Hiba; Rahmani, Jamal... more authors ... less authors ( Elsevier , 2021 , Other)Dear Editor, We appreciate the comments provided to us in the letter from Amiri et al. We would like to offer some clarifications in response to the comments. Firstly, the authors claimed that we included the control ... -
Impact of GGCX, STX1B and FPGS Polymorphisms on Warfarin Dose Requirements in European-Americans and Egyptians
Hamadeh, IS; Shahin, MH; Lima, SM; Oliveira, F; Wilson, L; Khalifa, SI; Langaee, TY; Cooper-DeHoff, RM; Cavallari, LH; Johnson, JA... more authors ... less authors ( Blackwell Publishing Ltd , 2016 , Article)Genotype-based algorithms that include VKORC1 and CYP2C9 genotypes are less predictive of warfarin dose variability in Africans as opposed to Europeans. Polymorphisms in GGCX, FPGS, or STX1B are associated with warfarin ...